碧科生物技術(shù)（上海）有限公司<br>德中碧科生物技術(shù)公司是一個(gè)年輕的國(guó)際性生物醫(yī)藥公司，總部設(shè)立于德國(guó)。碧科的技術(shù)專(zhuān)長(zhǎng)在于天然產(chǎn)物化學(xué)、組合化學(xué)、有機(jī)化學(xué)、結(jié)構(gòu)生物學(xué)、篩選技術(shù)等領(lǐng)域。碧科投身于發(fā)展和優(yōu)化新藥候選分子的研究項(xiàng)目，擁有新穎，完善的研發(fā)技術(shù)。碧科公司正在籌建一項(xiàng)獨(dú)特的教學(xué)計(jì)劃，旨于培養(yǎng)那些在生物技術(shù)領(lǐng)域有相同愛(ài)好的亞洲學(xué)生。作為這項(xiàng)計(jì)劃的成果之一便是bifloratm數(shù)據(jù)庫(kù)的建立。<br>碧科生物技術(shù)（上海）有限公司是碧科在中國(guó)的一個(gè)分支機(jī)構(gòu)。碧科以其創(chuàng)新、靈活、快捷的理念致力于新藥的研究，碧科成員的使命是加速新藥開(kāi)發(fā)的進(jìn)程，以持續(xù)地提高人們的生活質(zhì)量。碧科以其創(chuàng)新、靈活、快捷的理念從事現(xiàn)代藥物研究開(kāi)發(fā)。它運(yùn)用最具獨(dú)特性和優(yōu)越性的天然資源為出發(fā)點(diǎn)進(jìn)行新藥的開(kāi)發(fā)。碧科先進(jìn)的技術(shù)使其針對(duì)新藥開(kāi)發(fā)的強(qiáng)烈挑戰(zhàn)，能夠大大地縮短從藥物的發(fā)現(xiàn)到臨床階段這一漫長(zhǎng)而昂貴的進(jìn)程。<br>欲了解更多有關(guān)碧科生物技術(shù)（上海）有限公司的信息，請(qǐng)?jiān)L問(wèn)：www.bicoll-group.com<br>bicoll gmbh co. ltd. is a young biopharmaceutical company; the international corporation's headquarters is in munich, germany. bicoll's competencies include natural product chemistry as well as combinatorial chemistry, structural biology, organic chemistry, screening techniques, own developed novel deconvolution techniques, isolation strategies and structural elucidation. moreover bicoll launches into proprietary projects involving development and optimization of new drug candidates. bicoll is also involved in the sustainable use of biodiversity and related educational programs. as a result of its activities the bifloratm database was launched helping<br>bicoll biotechnology (shanghai) co. ltd. is a subsidiary company of bicoll gmbh. it provides an innovative, flexible and fast approach to modern drug discovery. the mission of bicoll is to accelerate the development process of new pharmaceuticals. evolution provides the cures to increase people's quality of life – sustainably. bicoll provides an innovative, fast and flexible approach in modern drug research. the company’s proprietary technology addresses the main challenge of drug research: the shorting of the long lasting and expensive process when going from discovery to (pre-) clinical testing<br><br>公司網(wǎng)站：www.bicoll-group.com<br>聯(lián)系方式：<br><br>郵政編碼：<br>聯(lián)系人：</p>